Search - tctmd.com

Displaying 61 - 80 of 692

Sort: Relevancy | Date

Presentation TCT 2025

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Presenter: Michael J. Mack

October 27, 2025

Presentation TCT 2025

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Presenter: Roseann M. White

October 27, 2025

Presentation TCT 2025

Commentary

Presenter: Bernard Prendergast

October 27, 2025

Presentation TCT 2025

How to Design (and How Not to Design) a Non-Inferiority Trial

Presenter: Kevin Bainey

October 27, 2025

Presentation TCT 2025

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Presenter: David J. Cohen

October 27, 2025

Presentation TCT 2025

Real-World Data from Data Aggregators: Opportunities and Challenges

Presenter: Ryan Ahern

October 27, 2025

Presentation TCT 2025

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Presenter: Robert W. Yeh

October 27, 2025

Presentation TCT 2025

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Presenter: Sreekanth Vemulapalli

October 27, 2025

Presentation TCT 2025

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Presenter: Eric A. Secemsky

October 27, 2025

Presentation TCT 2025

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Presenter: Mitchell W. Krucoff

October 27, 2025

Presentation TCT 2025

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Presenter: Jonathan G. Schwartz

October 26, 2025

Presentation TCT 2025

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Presenter: Raj Makkar

October 26, 2025

Presentation TCT 2025

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Presenter: Josep Rodés-Cabau

October 26, 2025

Presentation TCT 2025

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Presenter: Sahil A. Parikh

October 26, 2025

Presentation TCT 2025

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

Presenter: Robert A. Lookstein

October 26, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Jeffrey W. Moses

October 26, 2025

Presentation TCT 2025

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

Presenter: Matthias Bossard

October 26, 2025

Presentation TCT 2025

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Presenter: Sheriff Dodoo

October 26, 2025

Presentation TCT 2025

Commentary

Presenter: Antonio Colombo

October 26, 2025

Advertisement

Long-Term Follow-up of the PARTNER 3 Low-Risk Randomized Trial: Seven-Year Clinical and Echocardiographic Outcomes

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Commentary

How to Design (and How Not to Design) a Non-Inferiority Trial

Defining the Prevalence of Valvular Heart Disease in Older Americans: The PREVUE-VALVE Study

Real-World Data from Data Aggregators: Opportunities and Challenges

Hybrid Trial Designs and Real-World Evidence: Will They Ever Be Prime Time?

Rational Dispersion of Novel Technologies & the Need for Additional Evidence Generation: Lessons Learned from Recent CMS NCDs

Linkage of Clinical Trial Evidence with Administrative Claims: Pros and Cons

Swimming with the SHARCs: Advancing Harmonization of Definitions Used in Clinical Trials of Cardiogenic Shock

Lessons Learned from 800+ Patients Treated with Tricuspid TEER: Update from the TRILUMINATE Pivotal Trial

Evaluating Real-World Outcomes of the EVOQUE Valve in Early Commercial Experience from the STS/ACC TVT Registry

Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure

Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the Esprit™ BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions

Randomized Controlled Trial of Mechanical Thrombectomy with Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Results from STORM-PE

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Commentary

A Randomized, Multicenter, Non-Inferiority Comparison of Intravascular Lithotripsy and Super-High-Pressure Non-Compliant Balloons for Treatment of Calcified and Refractory Coronary Lesions - The VICTORY Trial

TCT 462: Clinical Outcomes Following Drug-Coated Balloon Versus Drug-Eluting Stent Strategies in the Treatment of Chronic Limb-Threatening Ischemia in Femoropopliteal Atherosclerotic Disease: A Meta-Analysis of Randomized Controlled Trials.

Commentary

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content